Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Drug Therapy, Combination × Clear all

Status

Completed 6 Not yet recruiting 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

HR+HER2- Advanced Breast Cancer 1

Interventions

pembrolizumab 380 Carboplatin 269 Cyclophosphamide 265 Nivolumab 258 Specimen Handling 215 Paclitaxel 214 Magnetic Resonance Spectroscopy 212 Cisplatin 206 Radiotherapy 191 Dexamethasone 161 Gemcitabine 156 durvalumab 154 Biopsy 148 atezolizumab 137 Lenalidomide 127 Doxorubicin 119 Rituximab 118 Bevacizumab 118 Docetaxel 116 Ipilimumab 114 Capecitabine 104 Oxaliplatin 103 Radiosurgery 101 Radiation 100 Fluorouracil 99 fludarabine 98 Etoposide 95 venetoclax 94 Prednisone 93 Pemetrexed 90

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06148506 2025-12-05

ValerEE

Novartis

Active not recruiting

HR+HER2- Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡